Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from QT Imaging Holdings ( (QTI) ) is now available.
On May 13, 2026, QT Imaging reported first-quarter 2026 revenue of $6.5 million, up 133% year over year, driven by the shipment of 13 Breast Acoustic CT scanners, though gross margin fell to 41% and the company posted a net loss of $3.4 million. Operating expenses rose as the company scaled commercialization and clinical activities, but net loss narrowed sharply due to lower nonrecurring financing charges, while cash and equivalents declined to $7.0 million at March 31.
Operationally, QT Imaging secured AMA approval for a dedicated Category III CPT code effective January 2027, gained FDA 510(k) clearance for improved posterior breast imaging, and obtained UAE regulatory clearance tied to a multi-year distribution deal with minimum orders worth over $24 million. The company also launched new viewing and software tools, uplisted to Nasdaq, extended the maturity of its senior secured term loan to March 31, 2029 at a higher interest rate, and reaffirmed its 2026 revenue guidance of about $39 million, underscoring an aggressive growth strategy but continued investment needs for global adoption.
The most recent analyst rating on (QTI) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on QT Imaging Holdings stock, see the QTI Stock Forecast page.
Spark’s Take on QTI Stock
According to Spark, TipRanks’ AI Analyst, QTI is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and cash burn despite improved equity) and limited valuation support (negative P/E, no dividend). These are partially offset by a constructive technical trend and positive corporate developments indicating accelerating commercialization and improved funding/liquidity.
To see Spark’s full report on QTI stock, click here.
More about QT Imaging Holdings
QT Imaging Holdings, Inc., based in Novato, California, is a medical device company focused on transforming breast health management with its radiation-free, compression-free, 3D Breast Acoustic CT imaging systems and related software. The company targets the breast imaging market globally, partnering with distributors such as NXC Imaging in the U.S. and regional medical device distributors in the Gulf region to drive adoption of its QTscan platform and cloud-based services.
Average Trading Volume: 39,661
Technical Sentiment Signal: Buy
Current Market Cap: $91.4M
For an in-depth examination of QTI stock, go to TipRanks’ Overview page.